Published: 06 October, 2020 | Volume 4 - Issue 1 | Pages: 012-017
Figure 2:
Predicted FEV1 pre- and post-therapy (1 month) with an inhaled corticosteroid FEV1, forced expiratory volume in 1 s. Our study revealed heterogenous effects of inhaled corticosteroid on patients with chronic obstructive pulmonary disease with a fractional nitric oxide concentration over 35 parts per billion.
Read Full Article HTML DOI: 10.29328/journal.aaai.1001020 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."